Literature DB >> 29152490

Implementing genetic screening for the management of hepatic disease.

Brittany Dewdney1, Lionel Hebbard1.   

Abstract

Entities:  

Year:  2017        PMID: 29152490      PMCID: PMC5673761          DOI: 10.21037/hbsn.2017.07.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

1.  Comparison of TGF-β, PDGF, and CTGF in hepatic fibrosis models using DMN, CCl4, and TAA.

Authors:  Hye-Jung Park; Hyeong-Geug Kim; Jing-Hua Wang; Min-Kyung Choi; Jong-Min Han; Jin-Seok Lee; Chang-Gue Son
Journal:  Drug Chem Toxicol       Date:  2015-06-05       Impact factor: 3.356

2.  Simtuzumab treatment of advanced liver fibrosis in HIV and HCV-infected adults: results of a 6-month open-label safety trial.

Authors:  Eric G Meissner; Mary McLaughlin; Lindsay Matthews; Ahmed M Gharib; Bradford J Wood; Elliot Levy; Ralph Sinkus; Kimmo Virtaneva; Dan Sturdevant; Craig Martens; Stephen F Porcella; Zachary D Goodman; Bittoo Kanwar; Robert P Myers; Mani Subramanian; Colleen Hadigan; Henry Masur; David E Kleiner; Theo Heller; Shyam Kottilil; Joseph A Kovacs; Caryn G Morse
Journal:  Liver Int       Date:  2016-07-06       Impact factor: 5.828

Review 3.  Hepatocellular carcinoma: recent trends in the United States.

Authors:  Hashem B El-Serag
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.

Authors:  A Blythe Ryerson; Christie R Eheman; Sean F Altekruse; John W Ward; Ahmedin Jemal; Recinda L Sherman; S Jane Henley; Deborah Holtzman; Andrew Lake; Anne-Michelle Noone; Robert N Anderson; Jiemin Ma; Kathleen N Ly; Kathleen A Cronin; Lynne Penberthy; Betsy A Kohler
Journal:  Cancer       Date:  2016-03-09       Impact factor: 6.860

Review 5.  The function and mechanisms of action of LOXL2 in cancer (Review).

Authors:  Linghong Wu; Ying Zhu
Journal:  Int J Mol Med       Date:  2015-09-02       Impact factor: 4.101

6.  Hic-5 deficiency attenuates the activation of hepatic stellate cells and liver fibrosis through upregulation of Smad7 in mice.

Authors:  Xiao-Feng Lei; Wenguang Fu; Joo-Ri Kim-Kaneyama; Tomokatsu Omoto; Takuro Miyazaki; Bo Li; Akira Miyazaki
Journal:  J Hepatol       Date:  2015-08-31       Impact factor: 25.083

7.  The global decrease in cancer mortality: trends and disparities.

Authors:  D Hashim; P Boffetta; C La Vecchia; M Rota; P Bertuccio; M Malvezzi; E Negri
Journal:  Ann Oncol       Date:  2016-01-22       Impact factor: 32.976

8.  Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition.

Authors:  Shigeki Nakagawa; Lan Wei; Won Min Song; Takaaki Higashi; Sarani Ghoshal; Rosa S Kim; C Billie Bian; Suguru Yamada; Xiaochen Sun; Anu Venkatesh; Nicolas Goossens; Gretchen Bain; Gregory Y Lauwers; Anna P Koh; Mohamed El-Abtah; Noor B Ahmad; Hiroki Hoshida; Derek J Erstad; Ganesh Gunasekaran; Youngmin Lee; Ming-Lung Yu; Wan-Long Chuang; Chia-Yen Dai; Masahiro Kobayashi; Hiromitsu Kumada; Toru Beppu; Hideo Baba; Milind Mahajan; Venugopalan D Nair; Michael Lanuti; Augusto Villanueva; Angelo Sangiovanni; Massimo Iavarone; Massimo Colombo; Josep M Llovet; Aravind Subramanian; Andrew M Tager; Scott L Friedman; Thomas F Baumert; Myron E Schwarz; Raymond T Chung; Kenneth K Tanabe; Bin Zhang; Bryan C Fuchs; Yujin Hoshida
Journal:  Cancer Cell       Date:  2016-12-12       Impact factor: 38.585

9.  Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition.

Authors:  S K Gupta; S Oommen; M-C Aubry; B P Williams; N E Vlahakis
Journal:  Oncogene       Date:  2012-02-27       Impact factor: 9.867

10.  Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.

Authors:  Jia-Ru Wu; Chi-Tan Hu; Ren-In You; Siou-Mei Pan; Chuan-Chu Cheng; Ming-Che Lee; Chao-Chuan Wu; Yao-Jen Chang; Shu-Chuan Lin; Chang-Shan Chen; Teng-Yi Lin; Wen-Sheng Wu
Journal:  Oncotarget       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.